Today's Reuters Health News Headlines - Yahoo! News:
|
|
Pills as good as stents for stable heart patients: analysis
Mon,27 Feb 2012 04:21 PM PST
Reuters - CHICAGO (Reuters) - Treating stable heart patients with a handful of pills works just as well as propping open blocked heart arteries with a stent, U.S. researchers said on Monday, adding to evidence that less-invasive, less-costly drug treatment works as well as implanting a medical device in such patients. Stents, made by companies such as Boston Scientific Corp, Abbott Laboratories and Medtronic Inc, are still the preferred treatment for opening up blocked heart arteries in patients rushed to the hospital with an acute heart attack. ... Full Story | Top |
Fake Avastin had salt, starch, chemicals: Roche
Mon,27 Feb 2012 03:03 PM PST
Reuters - (Reuters) - Counterfeit versions of the cancer drug Avastin found in Europe and the United States earlier this month contained salt, starch and a variety of chemicals, but none of the life extending medicine or any other biotech drug, Roche said. The Swiss drugmaker said on Monday that British health regulators sent it a small number of vials of the counterfeit Avastin to it for analysis. Roche analyzed three of the vials and found that they contained none of the injectable cancer medicine's active ingredient or any protein or biologic drug, the company said. ... Full Story | Top |
Early signs vitamin D might ease menstrual cramps
Mon,27 Feb 2012 02:56 PM PST
Reuters - NEW YORK (Reuters Health) - A small study suggests women plagued by menstrual cramps may find relief with vitamin D3, raising hopes that the dietary supplement could one day be an alternative to the painkillers and birth control pills that doctors now recommend. But the treatment involves a mega-dose of vitamin D -- 300,000 IUs -- which made one expert add a don't-try-this-at-home warning. "This study does suggest (vitamin D) may have a role for menstrual cramps and menstrual pain, but I certainly would not recommend taking doses this high at the present time," said Dr. ... Full Story | Top |
Many don't stick to bone drugs, despite counseling
Mon,27 Feb 2012 02:27 PM PST
Reuters - NEW YORK (Reuters Health) - People with the bone-thinning condition osteoporosis often skip the drugs they are prescribed, and telephone counseling does little to change that, according to new research. Researchers said osteoporosis is involved in more than two million fractures a year in the U.S., racking up medical costs of $19 billion. In addition to exercise and a healthy diet with enough calcium and vitamin D, as well as measures to prevent falls, medications may reduce the risk of broken bones -- which can take a serious toll on the health of old people. ... Full Story | Top |
Measles cases in Indiana rise to 17 for month
Mon,27 Feb 2012 01:11 PM PST
Reuters - INDIANAPOLIS (Reuters) - The number of people with measles in Indiana this month has grown to 17 with a fresh case linked to an unvaccinated person who travelled to a country where the disease is prevalent, state health officials said on Monday. Officials said they had confirmed the new case in Adams County in northeastern Indiana, but said it was unrelated to a rare outbreak of 16 cases that have been confirmed in central Indiana this month. ... Full Story | Top |
Pfizer buys vitamin C maker Emergen-C brands
Mon,27 Feb 2012 12:56 PM PST
Reuters - (Reuters) - Pfizer Inc on Monday said it had acquired privately held Alacer Corp, the largest U.S. maker of vitamin C products, bolstering Pfizer's array of vitamin brands and its consumer healthcare business. Pfizer, which sells the popular Centrum line of vitamins acquired through its 2009 purchase of Wyeth, did not disclose financial details. Alacer each year produces about 500 million packets of its Emergen-C brand of vitamin C, an effervescent powdered supplement available in 15 flavors. ... Full Story | Top |
Scientists find key to immortality for asexual worms
Mon,27 Feb 2012 12:18 PM PST
Reuters - LONDON (Reuters) - Who wants to live forever? Some flatworms do, even if it means no sex. British scientists have found that a species of flatworm can overcome the process of ageing to become potentially immortal and say their work sheds light on possibilities of alleviating ageing and age-related characteristics in human cells. ... Full Story | Top |
Nicotine quick-fix mouth spray helps some quitters
Mon,27 Feb 2012 10:41 AM PST
Reuters - NEW YORK (Reuters Health) - A mouth spray that delivers a dose of nicotine faster than patches and gums may help some smokers quit long-term, suggests a new study from Scandinavian and German researchers. In a controlled trial lasting a year, they found that compared with a non-medicated "placebo" spray, the nicotine mouth spray helped more than twice as many smokers quit. One reason, the team writes in the European Respiratory Journal, could be rapid delivery of nicotine to the bloodstream to relieve cravings when they strike. ... Full Story | Top |
Glaxo recalls hypertension drug made at Novartis plant
Mon,27 Feb 2012 08:51 AM PST
Reuters - (Reuters) - GlaxoSmithKline has recalled 394,230 bottles of its DynaCirc CR hypertension drug from the U.S. market after the manufacturer, Novartis, reported inconsistent packaging practices. The generic drug is manufactured at a Novartis plant in Lincoln, Nebraska. Glaxo said in a statement that it has received no reports of adverse events, nor any complaints of contamination or tablet mix-ups in batches of the drug, but decided on the recall as a precautionary measure. The London-based company said it does not known when the Novartis facility will resume operations. ... Full Story | Top |
China sends man to labor camp for SARS rumor
Mon,27 Feb 2012 08:49 AM PST
Reuters - BEIJING (Reuters) - Police in a north China city said on Monday that they have sentenced a man to two years of "labor re-education" for spreading rumors of an outbreak of the SARS virus in the city. The man, surnamed Liu, was sentenced on Sunday to labor re-education "in accordance with the law," according to a police statement in Baoding city in Hebei province. The announcement was published on the Baoding public security bureau's website. ... Full Story | Top |
Regeneca recalls dietary supplement
Mon,27 Feb 2012 08:49 AM PST
Reuters - WASHINGTON (Reuters) - Regeneca Inc. is voluntarily recalling its single-capsule RegenErect dietary supplement because it contains an unlisted product used to correct male erectile dysfunction, the Irvine, California, company said. The capsules contain tadalafil, making them unapproved new drugs, and tadalafil is not listed in the label, the company said in a Friday statement carried on the Food and Drug Administration website. Tadalafil is used as a treatment for male erectile dysfunction. ... Full Story | Top |
Otsuka America receives FDA nod for breath test in children
Mon,27 Feb 2012 08:48 AM PST
Reuters - (Reuters) - U.S. health regulators have approved Otsuka America Pharmaceutical's breath test to detect bacterial infection that causes stomach inflammation and ulcer, for use in children aged 3 to 17 years. A press release from the U.S. Food and Drug Administration said BreathTek UBT was the first breath test to detect Helicobacter pylori bacterial infections in children. Rockville, Maryland-based Otsuka America, a unit of Japan's Otsuka Holdings Co Ltd, was granted approval to market its breath test for use in adults in 1996. ... Full Story | Top |
Fitness DVDs remain hale and hardly over the hill
Mon,27 Feb 2012 08:47 AM PST
Reuters - NEW YORK (Reuters) - Despite the brave new workout world of streaming videos and smart phone exercise apps, the old-fangled fitness DVD has never been in better shape. As people seek to live healthier, it remains the go-to workout aid for many who like their exercise accessible, inexpensive and private, according to a recent report. "Consumers are getting more and more advice from doctors to exercise," said Agata Kaczanowska, industry analyst for IBIS, which conducted a market research study of the $264 million-dollar fitness DVD industry. ... Full Story | Top |
FDA rejects Watson/Columbia premature birth drug
Mon,27 Feb 2012 08:46 AM PST
Reuters - (Reuters) - U.S. health regulators have rejected a vaginal gel from Watson Pharmaceuticals and Columbia Laboratories aimed at reducing the risk of premature birth, the companies said on Monday. The Food and Drug Administration told the companies that the data was not strong enough to support approval of the Prochieve drug and that they needed to do additional clinical studies, Watson and Columbia said. ... Full Story | Top |
| |
|
No comments:
Post a Comment